Actavis Generics Overview

  • Year Founded
  • 1956

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

  • Investments
  • 15

Actavis Generics General Information

Description

Provider of generic pharmaceutical products. The company provides generic pharmaceutical products for human use covering alimentary tract and metabolism, cardiovascular system, central nervous system, genito-urinary and sex hormones, anti-infective, musculo-skeletal system, oncology, respiratory system and dermatological therapeutic categories.

Contact Information

Website
www.actavis.com
Formerly Known As
Pharmaco
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Turmstrasse 24
  • 6300 Zug
  • Switzerland
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Turmstrasse 24
  • 6300 Zug
  • Switzerland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Actavis Generics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Actavis Generics‘s full profile, request access.

Request a free trial

Actavis Generics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of generic pharmaceutical products. The company provides generic pharmaceutical products for human use covering
Pharmaceuticals
Zug, Switzerland
25,000 As of 2025

Copenhagen, Denmark
 

Monmouth Junction, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Actavis Generics Competitors (13)

One of Actavis Generics’s 13 competitors is H. Lundbeck, a Corporation company based in Copenhagen, Denmark.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
H. Lundbeck Corporation Copenhagen, Denmark
Tris Pharma Private Debt Financed Monmouth Junction, NJ
Bluefish Pharmaceuticals Private Equity-Backed Stockholm, Sweden
Alvogen Group Formerly PE-Backed Morristown, NJ
MS Pharma Private Equity-Backed Amman, Jordan
You’re viewing 5 of 13 competitors. Get the full list »

Actavis Generics Patents

Actavis Generics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018148361-A1 Process for the preparation of remimazolam and solid state forms of remimazolam salts Inactive 09-Feb-2017
US-10993943-B2 Crystalline forms of selinexor and process for their preparation Inactive 05-Jan-2017
EP-3565813-A1 Novel crystalline forms of selinexor and process for their preparation Inactive 05-Jan-2017
US-20190336499-A1 Novel crystalline forms of selinexor and process for their preparation Active 05-Jan-2017
US-20210244729-A1 Novel crystalline forms of selinexor and process for their preparation Inactive 05-Jan-2017 A61K31/497
To view Actavis Generics’s complete patent history, request access »

Actavis Generics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Actavis Generics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Actavis Generics‘s full profile, request access.

Request a free trial

Actavis Generics Investments & Acquisitions (15)

Actavis Generics’s most recent deal was a Buyout/LBO with PharmaPack International. The deal was made on 02-Dec-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PharmaPack International 02-Dec-2011 Buyout/LBO Other Pharmaceuticals and Biotechnology
Specifar Pharmaceuticals 25-May-2011 Merger/Acquisition Pharmaceuticals
M8 Pharmaceuticals 14-Oct-2010 Later Stage VC Distributors (Healthcare)
Pfizer (Nerviano Manufacturing Site) 28-Jan-2008 Buyout/LBO Buildings and Property
Abrika Pharmaceuticals 23-Apr-2007 Merger/Acquisition Drug Delivery
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Actavis Generics Exits (9)

Actavis Generics’s most recent exit was on 14-Oct-2010 from M8 Pharmaceuticals. The exit was categorized as with 5 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
M8 Pharmaceuticals 14-Oct-2010 Completed
  • 5 buyers
ZAO ZiO-Zdorovye 20-Nov-2006 Completed
Higia 09-Dec-2005 Completed
Actavis Foshan Pharmaceutical 01-Jan-2005 Completed
Foshan Chiral Pharmaceutical 01-Jan-2005 Merger/Acquisition Completed
You’re viewing 5 of 9 exits. Get the full list »

Actavis Generics FAQs

  • When was Actavis Generics founded?

    Actavis Generics was founded in 1956.

  • Where is Actavis Generics headquartered?

    Actavis Generics is headquartered in Zug, Switzerland.

  • What is the size of Actavis Generics?

    Actavis Generics has 25,000 total employees.

  • What industry is Actavis Generics in?

    Actavis Generics’s primary industry is Pharmaceuticals.

  • Is Actavis Generics a private or public company?

    Actavis Generics is a Private company.

  • What is the current valuation of Actavis Generics?

    The current valuation of Actavis Generics is .

  • What is Actavis Generics’s current revenue?

    The current revenue for Actavis Generics is .

  • Who are Actavis Generics’s investors?

    ALMC, Allergan, Landsbankinn, and Novator Partners have invested in Actavis Generics.

  • Who are Actavis Generics’s competitors?

    H. Lundbeck, Tris Pharma, Bluefish Pharmaceuticals, Alvogen Group, and MS Pharma are some of the 13 competitors of Actavis Generics.

  • When was Actavis Generics acquired?

    Actavis Generics was acquired on 01-Jul-2016.

  • Who acquired Actavis Generics?

    Actavis Generics was acquired by Teva Pharmaceutical Industries.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process